Clinical evaluation of cefotiam in the treatment of bacteremia caused by Escherichia coli, Klebsiella species, and Proteus mirabilis: A retrospective study.

MLA

Hashiguchi, Yumi, et al. “Clinical Evaluation of Cefotiam in the Treatment of Bacteremia Caused by Escherichia Coli, Klebsiella Species, and Proteus Mirabilis: A Retrospective Study.” Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy, vol. 26, no. 11, Nov. 2020, pp. 1158–63. EBSCOhost, https://doi.org/10.1016/j.jiac.2020.06.007.

APA

Hashiguchi, Y., Oda, K., Katanoda, T., Nosaka, K., Jono, H., & Saito, H. (2020). Clinical evaluation of cefotiam in the treatment of bacteremia caused by Escherichia coli, Klebsiella species, and Proteus mirabilis: A retrospective study. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy, 26(11), 1158–1163. https://doi.org/10.1016/j.jiac.2020.06.007

Chicago

Hashiguchi, Yumi, Kazutaka Oda, Tomomi Katanoda, Kisato Nosaka, Hirofumi Jono, and Hideyuki Saito. 2020. “Clinical Evaluation of Cefotiam in the Treatment of Bacteremia Caused by Escherichia Coli, Klebsiella Species, and Proteus Mirabilis: A Retrospective Study.” Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy 26 (11): 1158–63. doi:10.1016/j.jiac.2020.06.007.